BECTON, DICKINSON AND COMPANY Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BECTON, DICKINSON AND COMPANY payments for repurchase of common stock for the quarter ending 2026-06-30 was $0.00.
- BECTON, DICKINSON AND COMPANY payments for repurchase of common stock for the quarter ending 2026-03-31 was $2.00B.
- BECTON, DICKINSON AND COMPANY payments for repurchase of common stock for the quarter ending 2025-12-31 was $250.00M, a 66.67% decline year-over-year.
- BECTON, DICKINSON AND COMPANY payments for repurchase of common stock for the quarter ending 2025-09-30 was $250.00M.
- BECTON, DICKINSON AND COMPANY payments for repurchase of common stock for fiscal 2025 was $1.00B, a 100.00% increase from fiscal 2024.
- BECTON, DICKINSON AND COMPANY payments for repurchase of common stock for fiscal 2024 was $500.00M.
- BECTON, DICKINSON AND COMPANY payments for repurchase of common stock for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BECTON, DICKINSON AND COMPANY payments for repurchase of common stock for fiscal 2022 was $500.00M, a 71.43% decline from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | $2.50B derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $2.50B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $250.00M 10-Q · filed 2026-02-09 | $500.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | $250.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $1.00B 10-K · filed 2025-11-25 |
| 2025-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | $750.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $750.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $750.00M 10-Q · filed 2026-02-09 | $750.00M derived: sum of 4 quarters · filed 2026-02-09 |
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $500.00M 10-K · filed 2025-11-25 |
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | $500.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-01 | $500.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | $500.00M 10-Q · filed 2025-02-06 | $500.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $0.00 10-K · filed 2025-11-25 |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-01 | $500.00M derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-02 | |
| 2022-12-31 | $0.00 10-Q · filed 2024-02-01 | |
| 2022-09-30 | $500.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $500.00M 10-K · filed 2024-11-27 |
| 2021-09-30 | $750.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $1.75B 10-K · filed 2023-11-21 |
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $0.00 10-K · filed 2022-11-22 |
| 2019-09-30 | $0.00 10-K · filed 2021-11-24 | |
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $0.00 10-K · filed 2019-11-27 |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02 | $0.00 derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-03 | $0.00 derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-12-31 | $0.00 10-Q · filed 2018-02-06 | $0.00 derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $220.00M 10-K · filed 2019-11-27 |
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02 | $220.00M derived: sum of 4 quarters · filed 2018-11-21 |
| 2017-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-03 | $220.00M derived: sum of 4 quarters · filed 2018-11-21 |
| 2016-12-31 | $220.00M 10-Q · filed 2018-02-06 | $220.00M derived: sum of 4 quarters · filed 2018-11-21 |
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-21 | $0.00 10-K · filed 2018-11-21 |
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | |
| 2016-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-02 | |
| 2015-12-31 | $0.00 10-Q · filed 2017-02-02 | |
| 2015-09-30 | $0.00 10-K · filed 2017-11-22 | |
| 2014-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-23 | $400.00M 10-K · filed 2016-11-23 |
| 2014-06-30 | $187.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-06 | $444.00M derived: sum of 4 quarters · filed 2015-11-25 |
| 2014-03-31 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $307.00M derived: sum of 4 quarters · filed 2015-11-25 |
| 2013-12-31 | $189.00M 10-Q · filed 2015-02-06 | $339.00M derived: sum of 4 quarters · filed 2015-11-25 |
| 2013-09-30 | $44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-25 | $450.00M 10-K · filed 2015-11-25 |
| 2013-06-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-04 | $655.99M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $56.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-05 | $855.99M derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $300.00M 10-Q · filed 2014-02-10 | $1.40B derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-09-30 | $249.99M derived: 8-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.50B 8-K · filed 2015-03-13 |
| 2012-06-30 | $250.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-05 | $1.48B derived: sum of 4 quarters · filed 2013-11-27 |
| 2012-03-31 | $600.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | $1.44B derived: sum of 4 quarters · filed 2013-11-27 |
| 2011-12-31 | $399.87M 10-Q · filed 2013-02-07 | $1.06B derived: sum of 4 quarters · filed 2013-11-27 |
| 2011-09-30 | $227.17M derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $1.50B 10-K · filed 2013-11-27 |
| 2011-06-30 | $215.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-06 | $1.47B derived: sum of 4 quarters · filed 2012-11-21 |
| 2011-03-31 | $220.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-03 | $1.36B derived: sum of 4 quarters · filed 2012-11-21 |
| 2010-12-31 | $836.89M 10-Q · filed 2012-02-07 | $1.40B derived: sum of 4 quarters · filed 2012-11-21 |
| 2010-09-30 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-21 | $750.00M 10-K · filed 2012-11-21 |
| 2010-06-30 | $100.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-08-02 | $728.58M derived: sum of 4 quarters · filed 2011-11-23 |
| 2010-03-31 | $258.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-05-04 | $658.49M derived: sum of 4 quarters · filed 2011-11-23 |
| 2009-12-31 | $191.13M 10-Q · filed 2011-02-08 | $457.82M derived: sum of 4 quarters · filed 2011-11-23 |
| 2009-09-30 | $178.58M derived: 10-K 12 month − 10-Q 9 month · filed 2011-11-23 | $550.01M 10-K · filed 2011-11-23 |
| 2009-06-30 | $29.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-08-04 | $467.04M derived: sum of 4 quarters · filed 2010-11-24 |
| 2009-03-31 | $58.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-05-06 | |
| 2008-12-31 | $283.32M 10-Q · filed 2010-02-08 | |
| 2008-09-30 | $95.61M derived: 10-K 12 month − 10-Q 9 month · filed 2010-11-24 | $450.00M 10-K · filed 2010-11-24 |
| 2007-09-30 | $450.12M 10-K/A · filed 2010-01-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |